| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BIRB 0796 | CTRPv2 | pan-cancer | AAC | 0.082 | 0.03 |
| mRNA | CIL56 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.04 |
| mRNA | GSK525762A | CTRPv2 | pan-cancer | AAC | -0.06 | 0.05 |
| mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | -0.066 | 0.05 |
| mRNA | JW-55 | CTRPv2 | pan-cancer | AAC | 0.16 | 0.05 |
| mRNA | BRD-K20514654 | CTRPv2 | pan-cancer | AAC | 0.099 | 0.06 |
| mRNA | GDC-0879 | CTRPv2 | pan-cancer | AAC | -0.068 | 0.06 |
| mRNA | ML162 | CTRPv2 | pan-cancer | AAC | 0.064 | 0.06 |
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | -0.11 | 0.06 |
| mRNA | erlotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.071 | 0.06 |